Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00783081 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication
A Phase 2 study, sponsored by Kowa Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 387
- Enrollment target
NCT00783081 is a Phase 2 study that has completed, run by Kowa Research Institute. The registered enrollment target is 387 participants.
The verdict
NCT00783081, a Phase 2 study, has completed, sponsored by Kowa Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 387 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of K-134 for the treatment of intermittent claudication.
Interventions
- DRUG Placebo
- DRUG K-134
- DRUG Cilostazol 100 mg BID
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 387 participants |
| Start Date | 2008-11 |
| Est. Completion | 2010-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00783081
The ClinicalTrials.gov registry entry for NCT00783081 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 387 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kowa Research Institute, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00783081 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00783081 about?
NCT00783081 is a clinical study titled "Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication". The purpose of this study is to evaluate the safety and efficacy of K-134 for the treatment of intermittent claudication.
What is the current status of trial NCT00783081?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 387 participants. The study started on 2008-11. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00783081?
The interventions under investigation include: Placebo (DRUG), K-134 (DRUG), Cilostazol 100 mg BID (DRUG).
Who is sponsoring clinical trial NCT00783081?
This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.